Results 61 to 70 of about 6,363 (204)
Journal of Cosmetic Dermatology, Volume 24, Issue 10, October 2025.
Leila Riedel +3 more
wiley +1 more source
Oxidative Medicine and Cellular Longevity, Volume 2025, Issue 1, 2025.Increased levels of glutathione (GSH) and related antioxidant processes are thought to predict breast tumor aggressiveness and therapy response. In our 2012 review of 21 studies, we found that most patient breast tumors exhibited increased GSH levels compared to peritumoral tissue.
Michael P. Gamcsik, Dario Ramirez
wiley +1 more source
ANZ Journal of Surgery, Volume 94, Issue 12, Page 2140-2149, December 2024.Changes to the tumour bed following oncoplastic surgery complicate the administration of adjuvant radiotherapy. A framework for tumour bed classification is proposed (OPSURGE) to aid communication between oncoplastic surgeons and radiation oncologists, particularly when using a boost dose to the primary tumour site. Abstract Introduction Changes to the
Matthew Binks +6 more
wiley +1 more source
International Journal of Cancer, Volume 155, Issue 9, Page 1616-1628, 1 November 2024.What's new? Patients who undergo breast‐conserving surgery for breast cancer have a significant risk of recurrence if the healthy tissue left behind harbors cancer‐predisposing alterations. Here, the authors use a custom‐made gene panel, to potentially identify the risk of recurrence by detecting such alterations.
Maria Andreou +26 more
wiley +1 more source
Benign breast tumors may arise on different immunological backgrounds
Molecular Oncology, Volume 18, Issue 10, Page 2495-2509, October 2024.Benign breast tumors lack invasive potential, offering insights into tumor biology. Our study, using pathway analysis, identified immune‐related pathways distinguishing benign from malignant tumors. Five pathways linked to cytokine and interferon signaling correlated with overall survival.
Lilly Anne Torland +9 more
wiley +1 more source
American Journal of Medical Genetics Part A, Volume 194, Issue 10, October 2024.Abstract Myhre syndrome is an increasingly diagnosed ultrarare condition caused by recurrent germline autosomal dominant de novo variants in SMAD4. Detailed multispecialty evaluations performed at the Massachusetts General Hospital (MGH) Myhre Syndrome Clinic (2016–2023) and by collaborating specialists have facilitated deep phenotyping, genotyping and
Angela E. Lin +94 more
wiley +1 more source
Single‐cell transcriptional atlas of human breast cancers and model systems
Clinical and Translational Medicine, Volume 14, Issue 10, October 2024.Patient‐derived xenografts models more closely resemble patient samples in tumour heterogeneity and cell cycle characteristics when compared with cell lines. 3D organoid models exhibit differences in metabolic profiles compared to their in vivo counterparts. A valuable multimodel reference dataset that can be useful in elucidating model differences and
Julia E. Altman +16 more
wiley +1 more source
Chemical Biology &Drug Design, Volume 104, Issue 3, September 2024.Dehydroepiandrosterone‐α‐2‐deoxyglucoside (DHEA‐α‐2‐DG) is a rare stereospecific conjugate of DHEA and 2‐DG with anticancer activity far superior to that of 2‐DG, approximately four times that of DHEA, and better than that of polydatin. It also inhibited G6PD activity in vitro, decreased the NADPH/NADP+ ratio in MCF‐7 cell activity assay, and inhibited
Hsu‐Feng Liu +6 more
wiley +1 more source
Superior pedicle reduction mammoplasty supported by central glandular pedicle
, 2021 Mohammed Megahed +3 more
openalex +1 more source
Superficial thrombophlebitis (Mondor′s Disease) after breast augmentation surgery
Indian Journal of Plastic Surgery, 2008 Although the aetiology of Mondor′s disease remains unclear, the most commonly cited cause is trauma of some sort. Although surgical trauma has frequently been quoted, reports that specifically implicate aesthetic breast surgery are unusual in the ...
P. Viana Giovanni Andre +1 more
doaj +1 more source